IP Library Granted Patent US 8,592,602
Granted Patent B2
US 8,592,602 · App. 13/351,573 · Granted Nov 26, 2013

Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

Inventor: David Siesel (San Diego, CA)
Assignee: Vertex Pharmaceuticals Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,592,602
App. No.
13/351,573
Granted
Nov 26, 2013
Kind
B2
Abstract

The present invention relates to a process of providing the 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in substantially free form (Compound 1).

Claims (29)

1. A process for preparing a compound of formula 1:

comprising the step of:

ia) reacting a compound of formula 6a:

wherein,

R is H or C 1-6 aliphatic;

R 1 is independently selected from —R J , —OR J , or —CO 2 R J ;

R J is hydrogen or C 1-6 aliphatic;

o is an integer from 0 to 3 inclusive; and

p is an integer from 0 to 5 inclusive;

with a compound of formula 7a:

wherein,

A is a fused heterocycloalkyl;

R 1 is independently selected from —R J or —OR J ;

R J is hydrogen or C 1-6 aliphatic;

m is an integer from 0 to 3 inclusive;

n is an integer from 1 to 4 inclusive; and

X is a halo or OH;

in an organic solvent in the presence of a base.

2. The process of claim 1 , wherein the organic solvent is an aprotic solvent.

3. The process of claim 1 , wherein the organic solvent is toluene.

4. The process of claim 1 , wherein the base is an organic base.

5. The process of claim 1 , wherein the base is triethylamine.

6. The process of claim 1 , wherein the reaction between compound 6a and compound 7a is carried out in the presence of a catalytic amine.

7. The process of claim 1 , wherein the reaction between compound 6a and compound 7a is carried out in the presence of a catalytic amount of dimethylaminopyridine.

8. The process of claim 1 , wherein when R 1 on the phenyl ring in formula 1 is an ester, the process further comprises de-esterifying the compound of formula 1 in a biphasic mixture comprising water, an organic solvent, and an acid to give an acid salt.

9. The process of claim 8 , wherein the organic solvent is acetonitrile.

10. The process of claim 8 , wherein the acid is an inorganic acid.

11. The process of claim 8 , wherein the acid is hydrochloric acid.

12. The process of claim 8 , wherein the de-esterification reaction is run at between 20° C. and 60° C.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2017
From: MILLER, MARK THOMAS; MCCARTNEY, JASON; HADIDA RUAH, SARA SABINA; ZHOU, JINGLAN
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 043203/0136 →
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2016
From: MACQUARIE US TRADING LLC
To: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
Reel/Frame 040357/0001 →
ASSIGNEE CHANGE OF ADDRESS Recorded Feb 9, 2016
From: VERTEX PHARMACEUTICALS INCORPORATED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 037752/0752 →
SECURITY INTEREST Recorded Jul 10, 2014
From: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 033292/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2013
From: SIESEL, DAVID
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 031247/0418 →
Continuity (4)
Division 12327915 · Dec 4, 2008
Provisional Application 61012181 · Dec 7, 2007
Provisional Application 61109573 · Oct 30, 2008
Related Publication 20120190856A1 · Jul 26, 2012